Adipocyte-derived extracellular vesicles increase insulin secretion through transport of insulinotropic protein cargo
Adipocyte-derived extracellular vesicles (AdEVs) are membranous nanoparticles that convey communication from adipose tissue to other organs. Here, to delineate their role as messengers with glucoregulatory nature, we paired fluorescence AdEV-tracing and SILAC-labeling with (phospho)proteomics, and revealed that AdEVs transfer functional insulinotropic protein cargo into pancreatic β-cells. Upon transfer, AdEV proteins were subjects for phosphorylation, augmented insulinotropic GPCR/cAMP/PKA signaling by increasing total protein abundances and phosphosite dynamics, and ultimately enhanced 1st-phase glucose-stimulated insulin secretion (GSIS) in murine islets. Notably, insulinotropic effects were restricted to AdEVs isolated from obese and insulin resistant, but not lean mice, which was consistent with differential protein loads and AdEV luminal morphologies. Likewise, in vivo pre-treatment with AdEVs from obese but not lean mice amplified insulin secretion and glucose tolerance in mice. This data suggests that secreted AdEVs can inform pancreatic β-cells about insulin resistance in adipose tissue in order to amplify GSIS in times of increased insulin demand.
Top-30
Journals
|
1
2
3
|
|
|
Cell Reports
3 publications, 3.75%
|
|
|
International Journal of Molecular Sciences
3 publications, 3.75%
|
|
|
Nature Metabolism
3 publications, 3.75%
|
|
|
Cells
3 publications, 3.75%
|
|
|
Frontiers in Endocrinology
3 publications, 3.75%
|
|
|
ACS Nano
2 publications, 2.5%
|
|
|
Diabetes
2 publications, 2.5%
|
|
|
bioRxiv
2 publications, 2.5%
|
|
|
Obesity Reviews
2 publications, 2.5%
|
|
|
International Journal of Obesity
2 publications, 2.5%
|
|
|
Discover Oncology
1 publication, 1.25%
|
|
|
Molecular Nutrition and Food Research
1 publication, 1.25%
|
|
|
Experimental Cell Research
1 publication, 1.25%
|
|
|
Advances in Protein Chemistry and Structural Biology
1 publication, 1.25%
|
|
|
Stem Cells International
1 publication, 1.25%
|
|
|
Annual Review of Physiology
1 publication, 1.25%
|
|
|
EMBO Molecular Medicine
1 publication, 1.25%
|
|
|
Food Frontiers
1 publication, 1.25%
|
|
|
Signal Transduction and Targeted Therapy
1 publication, 1.25%
|
|
|
iScience
1 publication, 1.25%
|
|
|
Biomedicines
1 publication, 1.25%
|
|
|
Experimental and Molecular Medicine
1 publication, 1.25%
|
|
|
Scientific Reports
1 publication, 1.25%
|
|
|
Journal of Endocrinology
1 publication, 1.25%
|
|
|
Molecular Therapy
1 publication, 1.25%
|
|
|
Journal of Translational Medicine
1 publication, 1.25%
|
|
|
Oncogene
1 publication, 1.25%
|
|
|
Aesthetic Plastic Surgery
1 publication, 1.25%
|
|
|
Nature Nanotechnology
1 publication, 1.25%
|
|
|
1
2
3
|
Publishers
|
5
10
15
20
25
|
|
|
Springer Nature
24 publications, 30%
|
|
|
Elsevier
15 publications, 18.75%
|
|
|
Cold Spring Harbor Laboratory
10 publications, 12.5%
|
|
|
MDPI
9 publications, 11.25%
|
|
|
Wiley
6 publications, 7.5%
|
|
|
Frontiers Media S.A.
4 publications, 5%
|
|
|
American Chemical Society (ACS)
3 publications, 3.75%
|
|
|
American Diabetes Association
2 publications, 2.5%
|
|
|
Annual Reviews
2 publications, 2.5%
|
|
|
American Society for Clinical Investigation
2 publications, 2.5%
|
|
|
Hindawi Limited
1 publication, 1.25%
|
|
|
Bioscientifica
1 publication, 1.25%
|
|
|
The Endocrine Society
1 publication, 1.25%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.